Coromandel International Q2 Profit Declines to Rs 523 Crore; Revenue Rises

CHEMICALS
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Coromandel International Q2 Profit Declines to Rs 523 Crore; Revenue Rises

Coromandel International reported consolidated revenue of Rs 10,294 crore for the quarter ended September 30, 2026, marking a rise from the previous year. However, net profit fell to Rs 523 crore from Rs 793 crore in the year-ago period. The company also announced the re-appointment of Sudarshan Venu as an Independent Director and a loan-to-equity conversion in its subsidiary, BMCC.

Coromandel International Reports Q2 Results

Consolidated Revenue: Rs 10,294.13 crore
Consolidated Net Profit: Rs 523.37 crore

Reader Takeaway: Revenue grew year-over-year, but net profits faced pressure due to rising costs or margin challenges.

What just happened

Coromandel International has released its financial results for the quarter ended September 30, 2026. While the company recorded growth in its top-line revenue, reaching Rs 10,294.13 crore compared to Rs 9,654.13 crore in the same period last year, its bottom-line profitability saw a decline. Consolidated Profit After Tax (PAT) stood at Rs 523.37 crore, down from Rs 793.44 crore in the second quarter of the previous year.

Why this matters

The divergence between revenue growth and profit contraction suggests increased input costs or changes in product mix that impacted margins. Investors will need to assess the company’s ability to manage operational costs in the current market environment.

Board and Management Updates

The Board of Directors approved the re-appointment of Mr. Sudarshan Venu as an Independent Director for a second five-year term, running from February 3, 2027, to February 2, 2032. This reappointment is subject to shareholder approval via postal ballot.

Transaction Details

The company completed a capital restructuring of its step-down subsidiary, Baobab Mining and Chemicals Corporation (BMCC). A loan of USD 9.70 million was converted into 1,11,355 equity shares. This follows prior approval from the Audit Committee and Board of Directors.

What to track next

Monitor the upcoming postal ballot results regarding the board appointment and look for commentary on margin recovery in future analyst calls.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.